Overexpression of ERBB2 was also seen in 7 of 18 DSRCT cases44, and a recent study also showed that treatment of DSRCT cell lines with ERBB ligands could activate ERBB2 and stimulate DSRCT cell growth45. The gene discussed is ERBB2; the disease is desmoplastic small round cell tumor.